940 resultados para Rule 12g3-2(b)
Resumo:
A associação entre prevalência de marcadores sorológicos de hepatite B e local de nascimento, verificado em estudo realizado num município de características rurais do Estado de São Paulo, Cássia dos Coqueiros, sugere existirem diferenças entre migrantes e não-migrantes no que diz respeito a fatores de risco para hepatite B. Esses dois grupos foram analisados segundo as variáveis escolaridade, ocupação profissional, número de hospitalizações, antecedente de transfusões sangüíneas e tipo de tratamento dentário prévio. A comparação entre os grupos mostra que migrantes, particularmente de outros Estados do País, apresentam baixos níveis de escolaridade, elevadas proporções de lavradores empregados, maior número de internações prévias e maiores exposições a transfusões sangüíneas e a procedimentos odontológicos mais agressivos. Observaram-se ainda associações entre a prevalência de marcadores de hepatite B e as variáveis escolaridade, ocupação profissional, número de hospitalizações e tipo de tratamento odontológico, muito embora as duas últimas não justifiquem as maiores prevalências entre os migrantes. A distribuição diferenciada de marcadores de hepatite B parece ser resultado da pior condição socioeconômica dos migrantes, refletida pelo seu nível inferior de escolaridade e pela predominância de ocupações secundárias.
Resumo:
A educação de crianças com necessidades educativas especiais (NEE) coloca nos nossos dias grandes desafios às escolas e famílias. A Inclusão apresenta-se neste contexto como a expressão chave, reveladora de um novo olhar e decidir, expressa na legislação, no discurso político e nas actuais disposições académicas e pedagógicas. Não obstante, nem todos os alunos com NEE dispõem de respostas integralmente inclusivas. Os alunos com espectro de Autismo, por exemplo, colocam às escolas e aos pais sérios problemas, os quais, devido à sua intensidade e variabilidade, questionam sem dúvida o sentido das respostas educativas adequadas a alunos portadores desta problemática. O objectivo geral deste estudo é, neste contexto, procurar aceder a um conhecimento mais actualizado sobre uma Unidade de Ensino Estruturado no atendimento a alunos com espectro de Autismo (UEEA). Pretende-se de modo mais específico aceder ao que pensam os professores sobre o atendimento educativo a alunos com espectro de Autismo e caracterizar uma unidade de ensino estruturado no que respeita aos recursos humanos, físicos e materiais, bem como as estratégias de trabalho privilegiadas no atendimento a este tipo de alunos e formas de colaboração entre técnicos e famílias. No sentido de melhor compreender e aprofundar esta problemática foram realizadas entrevistas semi-directivas a 3 professores do ensino especial com experiência em UEEA e a 3 professores do ensino regular. A escolha dos professores baseou-se em critérios relacionados com a sua experiência no atendimento a alunos com problemas de Autismo. A natureza do objecto de estudo induziu a um desenho de investigação de natureza interpretativa de carácter descritivo - Estudo de caso. O corpus do trabalho foi constituído pelas entrevistas semi-directivas, sujeitas a uma análise qualitativa de acordo com os procedimentos previsto para a análise de conteúdo. Com base na análise dos dados recolhidos, foi possível identificar e caracterizar aspectos relevantes sobre o que pensam os professores sobre a intervenção educativa de alunos com espectro de Autismo e sobre as respostas educativas existentes na UEEA.
Resumo:
A dor lombar é um dos distúrbios músculo-esqueléticos mais comuns, verificando-se um aumento na última década em crianças. O objectivo deste estudo foi determinar a prevalência de dor lombar não específica no último mês e no último ano em crianças em idade escolar. O estudo foi do tipo observacional descritivo transversal, a amostra foi constituída por 219 alunos entre os 10 e os 16 anos. Os instrumentos usados foram um questionário para a dor lombar, fita métrica e balança. Concluiu-se que prevalência de dor lombar na população estudada é elevada. Verificamos associação entre a dor lombar e o sexo feminino.
Resumo:
To evaluate the effect of concurrent infection by HIV on HBV infection or immunity, we have studied a group of 66 HIV1+ symptomatic Caucasian patients and another of 38 African HIV2+ asymptomatic individuals, concerning their HBV status: serological markers of infection and presence of HBV-DNA in serum, the last taken as sign of hepatitis B virus active replication, were monitored. HIV+ groups were compared with seronegative controls, adequately matched for age, sex and ethnological background. HBV DNA was found in 7.6% of HIV1+ Caucasian patients and 3.2% of seronegative controls; in African HIV2+ individuals 2.6% were also HBV DNA+, a percentage close to that found in HIV2 seronegative controls (2.9%). No correlation was found between HIV infection and HBV active replication. Immunodepression that follows HIV infection over time may be compatible with a degree of T cell function capable of avoiding reinfection with or reactivation of HBV, even in symptomatic stages of acquired immunodeficiency syndrome. Our findings are relevant to the choice of preventive strategies in populations at risk for HIV and HBV infection.
Resumo:
Dissertação de Mestrado em Ensino do Português como Língua Segunda e Estrangeira
Resumo:
Os autores estudam a ação do ciclamato e do cloridrato de 2, 3, 5, 6, - Tetrahidro-6-fenil-imidazo (2,1-b) tiazol no tratamento da ascaridiose. Foram tratados ao todo 84 indivíduos sendo 48 com o cloridrato e 36 com o ciclamato. O índice de cura com o primeiro foi de 83,9% e com o segundo de 76,4%. Nenhuma reação colateral foi observada com o emprêgo do cloridrato sendo que com o ciclamato 53,6 dos pacientes apresentaram sintomas discretos de intolerância. Os índices de cura assemelham-se aos observados com a piperazina que é a medicação clássica para terapêutica da ascaridiose.
Resumo:
The purpose of this study was to determine the seroprevalence of human immunodeficiency virus (HIV-1/2), human T-cell lymphotropic virus (HTLV-I/II), hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among 63 male prisoners in Manhuaçu, Minas Gerais, Brazil and to compare this with data from eligible blood donors. The positive results were as follows: 11/63 (17.5%) for HBV, 5/63 (7.4%) for syphilis, 4/63 (6.3%) for HCV, 3/63 (4.8%) for Chagas' disease, 2/63 (3.2%) for HIV-1/2 and 1/63 (1.6%) for HTLV-I/II. The seroprevalence in prisoners was higher than among blood donors, mainly for antibodies to HIV-1/2, HCV and HBV. This is probably due to low social economic level, illiteracy, higher proportion with a prior history of intravenous drug use and/or unsafe sexual behavior. Therefore, these prisoners constitute a high risk group and routine screening and counseling are recommended.
Resumo:
Magdeburg, Univ., Fak. für Naturwiss., Diss., 2014
Resumo:
Detail of Untitled 2, 2011, pastel on paper.
Resumo:
The latex of Euphorbia splendens var. hispolii in 12 ppm concentration (12 mg/l) caused 100% mortality for a Biomphalaria tenagophila population in a lotic habitat after 9 hr of dripfeed application. For sentinel snails, in cages placed at the water surface and buried under 0.10 m, the mortality rates varied with the distance from the application point and were: 100% (0 m); 92.6% (50 m) and 94.7% (100). No lethal effects were observed for the other living species in this habitat (Pomacea haustrum and Poecilia reticulata).
8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase
Resumo:
The enzyme trypanothione reductase is a recognised drug target in trypanosomatids and has been used in the search of new compounds with potential activity against diseases such as leishmaniasis, Chagas disease and African trypanosomiasis. 8-Methoxy-naphtho [2,3-b] thiophen-4,9-quinone was selected in a screening of natural and synthetic compounds using an in vitro assay with the recombinant enzyme from Trypanosoma cruzi. Its mode of inhibition fits a non-competitive model with respect to the substrate (trypanothione) and to the co-factor (NADPH), with Ki-values of 5 and 3.6 µM, respectively. When tested against human glutathione reductase, this compound did not display any significant inhibition at 100 µM, indicating a good selectivity against the parasite enzyme.
Resumo:
The molluscicidal evaluation of Euphorbia splendens var. hislopii (Crown of thorns) against Lymnaea columella snails, intermediate host of Fasciola hepatica, in irrigation ditches of the Pisciculture Station at Universidade Federal Rural do Rio de Janeiro, was studied under limited field conditions. An aqueous solution of the latex at 5 mg/l was tested in two irrigation ditches (experimental and control ditches), after initial sampling of the snail population present. Twenty-four hours after application of the product, it was verified that 97.4% of free L. columella snails and 100% of snails of the same species captive in cages and used as sentinels at three points equidistant from the application site in the experimental ditch, died. For Biomphalaria tenagophila and Melanoides tuberculata snails, present in the experimental ditch, the mortality was 100%, for the species Pomacea spp. the mortality was 40%. No mortality was verified in the free mollusks, or in the sentinels in the ditch used as control. E. splendens var. hislopii latex is thus an efficient natural molluscicide, which may be used as an alternative control agent against L. columella.
Resumo:
A total of 250 dentists (53.6% men and 46.4% women), with a mean age of 35.1 ± 9.8 years, were submitted to serological tests for the diagnosis of hepatitis B (HB) - HBsAg, anti-HBs, anti-HBc, HBeAg, and anti-HBe - using a radioimmunoassay. One or more of these markers were detected in 78 individuals (31.2%) who were excluded from the group to be vaccinated. Of the 172 HB-susceptible individuals, 135 (78.5%) responded to the call and were intradermally injected with three 2 µg doses of the Belgian HB recombinant vaccine, applied at an interval of one month between the 1st and 2nd dose and of five months between the 2nd and 3rd dose. A new determination of HB markers carried out 50 days after the 3rd dose showed that 110 (81.5%) individuals had become anti-HBs positive (65.5% good responders and 34.5% poor responders). Mean serum anti-HBs titer of these 110 dentists was 42.4 U S/N, similar in both sexes. The adverse effects analyzed in 106 dentists were: (a) local: pain (12.3%), burning sensation (14.1%), pruritus (25.5%), erythema (28.3%), local heat (18.9%), and a hypochromic spot (32.1%); (b) systemic (4.7%): discomfort in two patients, and fever, anorexia, and asthenia in one patient each. Intradermal administration of a fourth 2 µg vaccine dose to 39 dentists (poor or non-responders) increased the total number of anti-HBs-positive individuals from 110 (81.5%) to 114 (84.4%), with the number of good responders increasing from 72 (65.5%) to 85 (74.6%). We conclude that the Belgian recombinant vaccine applied in the scheme used here induces a high rate of seroconversion and causes only mild and transitory adverse effects.
Resumo:
Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 µg doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None of the dentists had hepatitis or had received HB vaccine during this period. All subjects were submitted to serological tests for the detection of the following markers of hepatitis B virus (HBV) infection: HBsAg, anti-HBc, HBeAg, anti-HBe, and anti-HBs, with no HBsAg, anti-HBc, HBeAg or anti-HBe being detected. A microparticle enzyme immunoassay (MEIA) revealed the presence of anti-HBs at protective titers (> 10 mIU/ml) in 42 dentists (82.4%), with the anti-HBs titer being higher than 100 mIU/ml in 36 of them (70.6%) (good responders), between 10 and 100 mIU/ml in 6 (11.8%) (poor responders), and lower than 10 mIU/ml in 9 (17.6%) (non-responders). According to clinical data and serological tests, none of the dentists had presented disease or latent HBV infection during the eight years following the first vaccination. A 2 µg booster dose was administered intradermally to eight dentists with anti-HBs titers lower than 10 mIU/ml (non-responders) and to six dentists with titers ranging from 10 to 100 mIU/ml (poor responders); the determination of anti-HBs one month later demonstrated the occurrence of seroconversion in the eight non-responders and an increase in anti-HBs titer in the six poor responders. In summary, the present results demonstrated the prolonged persistence of protection against HBV infection and the development of immunologic memory provided by vaccination against HB - with intra-dermal application of three 2 µg doses of the Belgian recombinant vaccine at 0, 1, and 6 months - carried out eight years before in 51 dentists.